
Sign up to save your podcasts
Or


On this episode of Where the Money Is, healthcare analysts David Williamson give their thoughts on the AbbVie and Infinity deal, hit on Novardis, and chat about CVS kicking their tobacco habit.
By The Motley FoolOn this episode of Where the Money Is, healthcare analysts David Williamson give their thoughts on the AbbVie and Infinity deal, hit on Novardis, and chat about CVS kicking their tobacco habit.